Ramesh P Arasaradnam Selected Research

Therapeutics

12/2022	Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial.
11/2022	Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: the IONIC trial protocol.
1/2021	Performance of the faecal immunochemical test for the detection of colorectal neoplasms and the role of proton pump inhibitors in their diagnostic accuracy.
12/2020	Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
12/2020	Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis-A multicentre study.
8/2017	Role of tissue microenvironment resident adipocytes in colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ramesh P Arasaradnam Research Topics

Disease

12	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2012
10	Neoplasms (Cancer) 04/2023 - 01/2014
9	Ulcerative Colitis 12/2023 - 09/2013
5	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 08/2023 - 01/2014
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2020
3	Crohn Disease (Crohn's Disease) 08/2023 - 02/2016
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2023 - 02/2016
3	Infections 11/2022 - 01/2020
3	Inflammation (Inflammations) 12/2020 - 01/2016
2	Liver Diseases (Liver Disease) 05/2023 - 12/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 12/2020
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2020 - 01/2014
1	Tuberculosis (Tuberculoses) 12/2023
1	End Stage Liver Disease 09/2023
1	Fibrosis (Cirrhosis) 05/2023
1	Liver Neoplasms (Liver Cancer) 05/2023
1	Hemorrhage 12/2022
1	COVID-19 11/2022
1	Human Influenza (Influenza) 11/2022
1	Polyps 10/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 08/2022
1	Sepsis (Septicemia) 08/2022
1	Clostridium Infections 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2020
1	Melanoma (Melanoma, Malignant) 12/2020
1	Skin Neoplasms (Skin Cancer) 12/2020
1	Heart Arrest (Cardiac Arrest) 12/2020
1	Disease Progression 09/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Margins of Excision 06/2019
1	Non-alcoholic Fatty Liver Disease 06/2015
1	Dysbiosis 01/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2014
1	IgA Deficiency 01/2013

Drug/Important Bio-Agent (IBA)

20	Volatile Organic CompoundsIBA 08/2023 - 09/2013
10	Biomarkers (Surrogate Marker)IBA 08/2023 - 07/2012
4	Ustekinumab (CNTO 1275)FDA Link 12/2023 - 12/2020
4	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2016
3	Peptides (Polypeptides)IBA 05/2023 - 12/2020
2	SeptinsIBA 05/2023 - 10/2021
2	C-Reactive ProteinIBA 12/2022 - 01/2020
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2022 - 11/2019
2	AlbuminsIBA 10/2021 - 09/2020
2	BilirubinIBA 10/2021 - 09/2020
2	Bile Acids and Salts (Bile Acids)IBA 11/2020 - 01/2015
1	Capsules (Microcapsules)IBA 01/2023
1	CalciumIBA 11/2022
1	vidofludimusIBA 11/2022
1	Antiviral Agents (Antivirals)IBA 11/2022
1	Therapeutic UsesIBA 11/2022
1	Oseltamivir (Tamiflu)FDA Link 11/2022
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2022
1	GasesIBA 08/2021
1	Proton Pump InhibitorsIBA 01/2021
1	4-sulfophenylmethallyl ether (SPME)IBA 12/2020
1	ProteomeIBA 12/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2020
1	ORALIT (ORS)IBA 01/2020
1	benzoyl L-arginine methyl ester (BAME)IBA 01/2020
1	Fibroblast Growth Factor 7 FDA Link 06/2019
1	SeleniumIBA 01/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016
1	Mitochondrial DNA (mtDNA)IBA 09/2014
1	acetamideIBA 09/2013
1	2-Propanol (Isopropyl Alcohol)FDA LinkGeneric 09/2013
1	AntibodiesIBA 01/2013
1	anti-transglutaminase autoantibodyIBA 01/2013

Therapy/Procedure

6	Therapeutics 12/2022 - 08/2017
1	Liver Transplantation 09/2023
1	Electronic Nose 08/2021
1	Transplantation 01/2021
1	Biological Therapy 01/2020
1	Chemoprevention 04/2015